Literature DB >> 6086951

Evidence for translational regulation of herpes simplex virus type 1 gD expression.

D C Johnson, P G Spear.   

Abstract

We compared the rates of synthesis of herpes simplex virus type 1 glycoproteins C and D and quantitated the accumulation of translatable mRNA for each glycoprotein at various times after infection. The rate of synthesis of gD increased sharply early in the infection, peaked by 4 to 6 h after infection, and declined late in the infection. In contrast, the rate of synthesis of gC increased steadily until at least 15 h after infection. The levels of mRNA for both of these glycoproteins, as detected by hybridization and by translation in vitro, continued to increase until at least 15 or 16 h after infection. Synthesis of both gC and gD and their respective mRNAs was found to be sensitive to inhibition of viral DNA replication with phosphonoacetic acid. The finding that reduced amounts of gD were synthesized late in the replicative cycle, whereas gD mRNA continued to accumulate in the cytoplasm, argues that the synthesis of gD is regulated, in part, at the level of translation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086951      PMCID: PMC254450     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Sodium ions and the shut-off of host cell protein synthesis by picornaviruses.

Authors:  L Carrasco; A E Smith
Journal:  Nature       Date:  1976 Dec 23-30       Impact factor: 49.962

2.  Regulation of herpesvirus macromolecular synthesis: evidence for multilevel regulation of herpes simplex 1 RNA and protein synthesis.

Authors:  B Roizman; M Kozak; R W Honess; G Hayward
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

4.  Regulation of herpesvirus macromolecular synthesis. VI. Synthesis and modification of viral polypeptides in enucleated cells.

Authors:  M Fenwick; B Roizman
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

5.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  RNA synthesis in cells infected with herpes simple virus. XIII. Differences in the methylation patterns of viral RNA during the reproductive cycle.

Authors:  M Bartkoski; B Roizman
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

8.  Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.

Authors:  R W Honess; D H Watson
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

9.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

10.  Synthesis and processing of glycoprotein D of herpes simplex virus types 1 and 2 in an in vitro system.

Authors:  J T Matthews; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

View more
  16 in total

1.  Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively?

Authors:  M Arsenakis; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Kinetics of expression of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1.

Authors:  L D Goodrich; F J Rixon; D S Parris
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Herpes simplex virus virion stimulatory protein mRNA leader contains sequence elements which increase both virus-induced transcription and mRNA stability.

Authors:  E D Blair; C C Blair; E K Wagner
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators.

Authors:  I H Gelman; S Silverstein
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  A single regulatory region modulates both cis activation and trans activation of the herpes simplex virus VP5 promoter in transient-expression assays in vivo.

Authors:  E D Blair; E K Wagner
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.

Authors:  S R Jennings; P A Lippe; K J Pauza; P G Spear; L Pereira; S S Tevethia
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Evidence that transcriptional control is the major mechanism of regulation for the glycoprotein D gene in herpes simplex virus type 1-infected cells.

Authors:  I L Smith; R M Sandri-Goldin
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

8.  Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation.

Authors:  D R Yager; D M Coen
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope.

Authors:  C C Flowers; D J O'Callaghan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Herpes simplex virus ICP27 increases translation of a subset of viral late mRNAs.

Authors:  Errin C Fontaine-Rodriguez; David M Knipe
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.